XT-203: a novel pain and substance abuse therapeutic

Ended Project Grant Awarded Last action

Award ID
W81XWH1810804
Recipient
Awarding agency
Obligated
$1,412,161

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Originally
Place of performance
Alameda, CA 94501, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment Covid-19 XT-203: a novel pain and substance abuse therapeutic extend the period of performance and DE-obligate funding 1. Per section 711 of the national… -$1,463,229
Amendment COVID19 XT-203: a novel pain and substance abuse therapeutic extend period of performance to 07/29/23 $0
Amendment Covid-19 XT-203: a novel pain and substance abuse therapeutic extend the period of performance $0
Amendment XT-203: a novel pain and substance abuse therapeutic - incorporate revised statement of work $0
Original award $2,875,390

Quick answers

Who received award W81XWH1810804?

W81XWH1810804 was awarded to Xalud Therapeutics, Inc. by Defense Health Agency (Department of Defense) on September 30, 2018.

How much is award W81XWH1810804 worth?

$1,412,161 has been obligated on W81XWH1810804.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login